SAFLUTAN Israel - English - Ministry of Health

saflutan

rafa laboratories ltd - tafluprost - ophthalmic solution - tafluprost 15 mcg/ml - tafluprost - tafluprost - reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.as monotherapy in patients • who would benefit from preservative free eye drops • insufficiently responsive to first line therapy • intolerant or contra-indicated to first line therapyas adjunctive therapy to beta-blockers.

Saflutan 15 micrograms/ml eye drops, solution, single-dose container Malta - English - Medicines Authority

saflutan 15 micrograms/ml eye drops, solution, single-dose container

santen oy niittyhaankatu 20, 33720 tampere, finland - tafluprost - eye drops, solution - tafluprost 15 µg/ml - ophthalmologicals

SAFLUTAN 15 Microgram/ML Eye Drops Solution Ireland - English - HPRA (Health Products Regulatory Authority)

saflutan 15 microgram/ml eye drops solution

primecrown 2010 ltd - tafluprost - eye drops solution - 15 microgram/ml - prostaglandin analogues

Saflutan 15 micrograms/ml eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

saflutan 15 micrograms/ml eye drops, solution

santen oy - tafluprost - eye drops, solution - 15 microgram(s)/millilitre - tafluprost

Saflutan 15 micrograms/ml, eye drops, solution in single-dose container Ireland - English - HPRA (Health Products Regulatory Authority)

saflutan 15 micrograms/ml, eye drops, solution in single-dose container

santen oy - tafluprost - eye drops, solution in single-dose container - 15 microgram(s)/millilitre - prostaglandin analogues1); tafluprost - antiglaucoma preparations and miotics, prostaglandin analogues - as monotherapy in patients:  who would benefit from preservative free eye drops  insufficiently responsive to first line therapy  intolerant or contra-indicated to first line therapy. as adjunctive therapy to beta-blockers.

SAFLUTAN Israel - English - Ministry of Health

saflutan

merck sharp & dohme israel ltd - tafluprost 15 mcg/ml - ophthalmic solution - tafluprost - reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.as monotherapy in patients • who would benefit from preservative free eye drops • insufficiently responsive to first line therapy • intolerant or contra-indicated to first line therapyas adjunctive therapy to beta-blockers.

Taflotan Ophthalmic Solution 0.0015% Singapore - English - HSA (Health Sciences Authority)

taflotan ophthalmic solution 0.0015%

santen pharmaceutical asia pte. ltd. - tafluprost - solution, sterile - 0.015mg/ml - tafluprost 0.015mg/ml

SAFLUTAN 15 micrograms/ml eye drops, solution, in single-dose container United Kingdom - English - myHealthbox

saflutan 15 micrograms/ml eye drops, solution, in single-dose container

santen oy - tafluprost - eye drops, solution in single-dose container - 15 micrograms - antiglaucoma preparations and miotics, prostaglandin analogues - reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension. as adjunctive therapy to beta-blockers

SAFLUTAN SOLUTION Canada - English - Health Canada

saflutan solution

purdue pharma - tafluprost - solution - 4.5mcg - tafluprost 4.5mcg - prostaglandin analogs